Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.5936
0.046.42%
At close: -
$0.5900
-0.00360-0.61%
After Hours: 6:06 PM EDT
Comments
Loading...
Lyell Immunopharma (LYEL) Forecast
NewsEarningsLyell Immunopharma (LYEL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Lyell Immunopharma Stock Price, Quotes and Forecasts | NASDAQ:LYEL | Benzinga
Explore Lyell Immunopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LYEL.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lyell Immunopharma (LYEL) stock?
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Who are Lyell Immunopharma (LYEL) competitors?
Other companies in Lyell Immunopharma’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Korro Bio (NASDAQ:KRRO).
What is the forecast, or price target, for Lyell Immunopharma (LYEL) stock?
Lyell Immunopharma has a consensus price target of $2.75.
What is the current price for Lyell Immunopharma (LYEL)?
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $0.59 last updated March 27, 2025 at 6:06 PM EDT.
Does Lyell Immunopharma (LYEL) pay a dividend?
There are no upcoming dividends for Lyell Immunopharma.
When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?
Lyell Immunopharma’s Q1 earnings are confirmed for Monday, May 5, 2025.
Is Lyell Immunopharma (LYEL) going to split?
There is no upcoming split for Lyell Immunopharma.
What sector and industry does Lyell Immunopharma (LYEL) operate in?
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.